MEOX1: a novel druggable target that orchestrates the activation of fibroblasts in cardiac fibrosis

Abstract excerpt

Single-cell genomic technology has been used to identify MEOX1 as a potential cell-specific, druggable target in cardiac fibrosis. To this effect, a landmark study was recently published in Nature by Alexanian and colleagues. 1

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cardiac Fibrosis and Remodeling
• Share to Peptidase Inhibition and Analysis
• Share to Signaling Pathways in Disease